U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: September 3-9, 2023
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: September 3-9, 2023

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 09/05/2023
Location: Virtual
Subject: Chronic Disease Working Session: Cardiovascular Disease
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of stakeholder groups that are interested in cardiovascular disease

Event Date: 09/06/2023
Location: Virtual
Subject: CDRH Patient Engagement Advisory Committee 2023 Meeting: Advancing Health Equity in Medical Devices
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, media, academia, and government

Event Date: 09/06/2023
Location: Washington, DC
Subject: Kidney Health Initiative Meeting: Defining the Next Decade of Kidney Innovation
FDA Participant/Group: JILL WASSERMAN; DAYLE CRISTINZIO;
Non FDA Participant/Group: Industry and government

Event Date: 09/07/2023
Location: Virtual
Subject: Chronic Diseases and Anti-obesity Medicines
FDA Participant/Group: NAMANDJE BUMPUS; HILARY MARSTON; JULIA TIERNEY;
Non FDA Participant/Group: Carl Garner, Dan Skovronsky, Dave Ricks (Eli Lilly);

Event Date: 09/07/2023
Location: Virtual
Subject: Items of Mutual Interest with Cancer Centers
FDA Participant/Group: MICHELLE ADAMS;
Non FDA Participant/Group: Industry, academia, and government

Event Date: 09/08/2023
Location: Virtual
Subject: Pediatric Over-the-Counter Analgesics
FDA Participant/Group: JULIA TIERNEY; MICHELLE ADAMS; HILARY MARSTON;
Non FDA Participant/Group: Caroline Tillet, Glen Murphy, Kathleen Widmer, Meredith Stevens, Rajesh Mishra (Kenvue);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Carol Cave, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 09/06/2023
Location: Virtual
Subject: International Coalition of Medicines Regulatory Authorities (ICMRA) Quarterly Executive Committee Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Member state representatives

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 09/07/2023
Location: Washington, DC
Subject: 2023 Annual Kidney Health Initiative Stakeholders Meeting: Reflections on Current and Future Activities of the Center for Biologics Evaluation and Research (CBER)
FDA Participant/Group: N/A
Non FDA Participant/Group: Kidney Health Initiative members, industry, research, and regulatory stakeholders

Event Date: 09/08/2023
Location: Virtual
Subject: International Society for Neurodegenerative Disease 7th Annual Meeting: FDA’s Efforts to Facilitate the Development of Biologic Products for Neurologic Diseases
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, healthcare, and patient stakeholders

Event Date: 09/08/2023
Location: Virtual
Subject: FDA - Biotechnology Innovation Organization Liaison Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from the Biotechnology Innovation Organization

Event Date: 09/09/2023
Location: Miami, FL
Subject: Cord Blood Association - Cord Blood Connect 2023 Meeting: Potential Alternative Programs to Facilitating the Availability of Cell and Gene Therapy Products
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, healthcare, and patient stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 09/06/2023
Location: Virtual
Subject: Patient Engagement Advisory Committee (PEAC) Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patients, caregivers, and representatives of patient organizations

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top